Reuters logo
in 7 months
BRIEF-Pain Therapeutics to discuss remoxy ER with FDA
December 20, 2016 / 2:10 PM / in 7 months

BRIEF-Pain Therapeutics to discuss remoxy ER with FDA

1 Min Read

Dec 20 (Reuters) - Pain Therapeutics Inc:

* Pain therapeutics to discuss remoxy ER with FDA

* Plans to meet with FDA in person on Monday, February 13, 2017 to discuss regulatory path forward for remoxy ER

* Pain therapeutics - during its upcoming meeting with FDA, company plans to open a scientific dialogue around intranasal (snorting) route of abuse

* Company will provide details of this FDA meeting after receipt of final meeting minute

* Pain therapeutics - company believes remoxy ER's thick, sticky, high-viscosity drug mass is a key feature of its abuse deterrent properties Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below